Customer Story New statistical monitoring tools optimize the drug development pipeline T o facilitate the transition away from traditional monitoring, many pharmaceutical companies have sought partnerships with experts in this growing field who can tailor solutions to their exact needs. Ferring Pharmaceuticals is one such company; Ferring’s biostatistics group has developed a partnership with NNE, a leading pharmaceutical engineer- ing consultancy, with vast experience in the drug development process both through manufacturing optimization and statistical support for clinical trials. “Our core competence is building factories in the pharmaceutical industry – alongside this we have a team of 200 consultants working to optimize and drive the best production, products, quality level

Join for free to read